Navigation Links
Raloxifene Reduces The Risk Of Breast Cancer

Studies show that 'Raloxifene' can reduce postmenopausal women with any risk levels of breast cancer. According to a new study that has been published in the September 1 issue of Clinical Cancer Research//, Raloxifene could protect postmenopausal women from developing invasive breast cancer immaterial of whether they are at high or low risk of developing the disease.

The study had also shown that the drug could reduce the risk in women with a family history of breast cancer to an equal level with women not having any family history.

Compared with a placebo drug, the study found that use of raloxifene was associated with a 58 percent reduction in breast cancer risk in women without a family history of the disease, and an 89 percent reduction in risk for women with a family history of breast cancer.

But the researchers say they cannot explain why protection seems greatest in women who may be genetically predisposed to develop the disease.

'We don't know what to make of this observation,' said Marc E. Lippman, M.D., professor in the Department of Internal Medicine at the University of Michigan and the study's lead author. 'It could be due to chance, or there may be other factors at work that we don't know about.'

'But our bottom-line analysis as to why raloxifene universally reduces the risk of developing invasive cancer in women without a family history is that it interferes with the duration and concentration of estrogen, which acts as a tumour promoter in the majority of breast cancers,' said Dr. Lippman.

The research team conducted a new analysis of the first large study of raloxifene, which tested the ability of the drug to prevent vertebral fractures in 7,705 postmenopausal women diagnosed with osteoporosis.

The secondary endpoint of this multi-centre, double-blind trial, known as MORE (Multiple Outcomes of Raloxifene Evaluation) was the drug's effect on breast cancer development;
'"/>




Page: 1 2 3

Related medicine news :

1. Raloxifene Better Than Tamoxifen For Breast Cancer
2. Drug Reduces Risk of Clogged Arteries, Veins
3. Sunshine Reduces MS Risk
4. Estrogen in Food Reduces Cancer Risk
5. Dental Procedure Reduces Preterm Births
6. Vaccine Reduces antibiotic-resistant infections in Children
7. Eating Fiber Reduces The Risk Of Heart Disease
8. Higher Statin Dose Safely Reduces Stroke and Cardiac Arrest
9. Anti-tobacco Advertising Can Reduces smoking Among Teens
10. Eating Fish Reduces Heart Disease
11. Co-trimoxazole Use Reduces Childhood AIDS –Related Death
Post Your Comments:
(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
Breaking Medicine News(10 mins):Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
...ct. 1 Sunnylife Global, Inc.,(Pink Sheets: SNYL) ...ns,and financial public relations services. At a ... quality,healthcare management in China and build ...We are thrilled to have been retained to represent...
...J., Oct. 1 Wedgewood Pharmacy and Midwest,Veterin...gency agreement,through which Midwest will represe...000 veterinary clinics in 27 states. The relations...gewood,s compounding services will,be offered to v...
...Oct. 1 In honor of Hispanic Heritage,Month in the...speakers,worldwide, the International Hyperhidrosi...version of its popular patient education brochure.... speak at,the 21st World Congress of Dermatology o...
...chultz Investigates the "Social Brain" in Children...ILADELPHIA, Oct. 1 An internationally,prominent e...ts with,autism, Robert T. Schultz, Ph.D., is joini... Most recently the director of the Yale Developmen...
..., Oct. 1 Merlyn Medical has announced,receipt of ...id warmer that,requires neither battery nor electr...2007 EMS Expo in Orlando, FL, October 11-13 and th...ation vehicles, field use, rescue, or other applic...
...est Distributors and Pharmacy Chains to Carry RESP...evice, NEW YORK and MAROOCHYDORE, Australia, Oct....hat its RESPeRATE(R) hypertension,treatment device... marketing and distribution partner, High Tech,Hea...
Other Medicine News:Health News:Sunnylife Global Retains The Blaine Group For Investor Relations, Financial Public Relations 2Health News:Wedgewood Pharmacy and Midwest Veterinary Supply Sign New Agency Agreement 2Health News:Wedgewood Pharmacy and Midwest Veterinary Supply Sign New Agency Agreement 3Health News:In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish 2Health News:Brain Imaging Expert Recruited to Study Autism at The Children's Hospital of Philadelphia 2Health News:Brain Imaging Expert Recruited to Study Autism at The Children's Hospital of Philadelphia 3Health News:Merlyn Medical Announces FDA Approval for FlexWarmer in a Joint Agreement with Elltec and Suzuken 2Health News:InterCure and High Tech Health Announce RESPeRATE Launch into Pharmacy Market in Australia 2Health News:InterCure and High Tech Health Announce RESPeRATE Launch into Pharmacy Market in Australia 3Health News:InterCure and High Tech Health Announce RESPeRATE Launch into Pharmacy Market in Australia 4
(Date:12/4/2009)BILLERICA, Mass., Dec. 4 Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: VOLC ), today announced the initial development and successful testing of a novel integra
(Date:12/4/2009)TARRYTOWN, N.Y., Dec. 4 Bayer Diabetes Care today announced the three grand prize winners of Bayer,s "Express Your Simple Win Creativity Contest." Nick Jonas, of the Jonas Brothers, selected the winn
(Date:12/4/2009)WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: AZN ) today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tab
Breaking Medicine Technology:Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Researchers Propose Improved Cervical Cancer Screening 57807 1Researchers Propose Improved Cervical Cancer Screening 57807 2Nanoresearchers challenge dogma in protein transportation in cells 10001 1Nanoresearchers challenge dogma in protein transportation in cells 10001 2American Lung Association of Arizona Kicks Off 2009 2010 Influenza Season In Phoenix 57802 1American Lung Association of Arizona Kicks Off 2009 2010 Influenza Season In Phoenix 57802 2American Lung Association of Arizona Kicks Off 2009 2010 Influenza Season In Phoenix 57802 3American Lung Association of Arizona Kicks Off 2009 2010 Influenza Season In Phoenix 57802 4American Lung Association of Arizona Kicks Off 2009 2010 Influenza Season In Phoenix 57802 5
...ounces a $50,000 Grant from,Verizon to help preven...HILADELPHIA, Feb. 7 The Center for Injury,Researc...ladelphia is,pleased to announce a $50,000 grant r...children after an injury. Researchers at the Cente...lies to develop effective,screening tools and inte...
...ologies, Inc. (Nasdaq: EMIS ) announced today tha... concept that absorption of oral vitamin,B12 using...s 15-30 times,greater than with the same dose of o...igen(R) technology is the basis of the company,s u...es and pharmaceutical compounds., "This data demo...
Other Medicine Technology:Helping Families Cope After an Injury 2Emisphere Technologies Announces Positive Results From Animal Studies on Oral B12 Using eligen(R) Technology 2Emisphere Technologies Announces Positive Results From Animal Studies on Oral B12 Using eligen(R) Technology 3
Gibco Penicillin-Streptomycin liquid
Gibco Antibiotic-Antimycotic (100X), liquid
Gentamicin, 50 mg/ml
GENTAMICIN SULFATE, 1000X
Medicine Products: